Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma
ClinicalTrials.gov study NCT04499339. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03380039. IPD Sharing: NO. Countries: 1. Publications: 0.
AHSCT Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT05740891. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Id and Rd Maintenance Regimens After Induction of Remission in Multiple Myeloma.
ClinicalTrials.gov study NCT05477797. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma
ClinicalTrials.gov study NCT02400242. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics
ClinicalTrials.gov study NCT04678089. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
ClinicalTrials.gov study NCT06142396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."
ClinicalTrials.gov study NCT04998786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Low Dose Dexamethasone Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone for Induction, in Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov study NCT01530594. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of OPD5 Followed by Autologous Stem Cell Transplant for Patients With Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04918511. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02144038. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma
ClinicalTrials.gov study NCT02978235. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
ClinicalTrials.gov study NCT05714839. IPD Sharing: YES. Countries: 10. Publications: 0.
An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06668792. IPD Sharing: NO. Countries: 1. Publications: 0.
A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma
ClinicalTrials.gov study NCT05448404. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relapsed or Relapsed-and-Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02189343. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
ClinicalTrials.gov study NCT06215118. IPD Sharing: NO. Countries: 3. Publications: 0.
TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03952091. IPD Sharing: Not stated. Countries: 2. Publications: 0.
CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT02362165. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma
ClinicalTrials.gov study NCT05355987. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.